State of Wisconsin Investment Board
ATOS icon

State of Wisconsin Investment Board’s Atossa Therapeutics ATOS Stock Holding History

State of Wisconsin Investment Board’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,087
Closed -$493K – 2156
2021
Q3 		$493K Hold
10,087
– – ﹤0.01% 1700
2021
Q2 		$956K Buy
+10,087
New +$534K ﹤0.01% 1466

Other funds holding ATOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of Wisconsin Investment Board's ATOS Position: Q4 2021 in Review

State of Wisconsin Investment Board sold out of Atossa Therapeutics (ATOS) in Q4 2021, closing a stake of 10,087 shares — an estimated $493K sold.

State of Wisconsin Investment Board first reported a position in ATOS in Q2 2021 and held it in 2 quarters. The position peaked at $956K in Q2 2021. 92 funds tracked by Wall St. Rank hold ATOS as of Q4 2021.

  • State of Wisconsin Investment Board reported no remaining Atossa Therapeutics position as of Q4 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 10,087 Atossa Therapeutics shares in Q4 2021, an estimated $493K.
  • State of Wisconsin Investment Board first reported a position in Atossa Therapeutics in Q2 2021 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Atossa Therapeutics position peaked at $956K in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.